208 related articles for article (PubMed ID: 35440565)
21. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.
Beekman R; Chapaprieta V; Russiñol N; Vilarrasa-Blasi R; Verdaguer-Dot N; Martens JHA; Duran-Ferrer M; Kulis M; Serra F; Javierre BM; Wingett SW; Clot G; Queirós AC; Castellano G; Blanc J; Gut M; Merkel A; Heath S; Vlasova A; Ullrich S; Palumbo E; Enjuanes A; Martín-García D; Beà S; Pinyol M; Aymerich M; Royo R; Puiggros M; Torrents D; Datta A; Lowy E; Kostadima M; Roller M; Clarke L; Flicek P; Agirre X; Prosper F; Baumann T; Delgado J; López-Guillermo A; Fraser P; Yaspo ML; Guigó R; Siebert R; Martí-Renom MA; Puente XS; López-Otín C; Gut I; Stunnenberg HG; Campo E; Martin-Subero JI
Nat Med; 2018 Jun; 24(6):868-880. PubMed ID: 29785028
[TBL] [Abstract][Full Text] [Related]
22. An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation.
Thynn HN; Chen XF; Hu WX; Duan YY; Zhu DL; Chen H; Wang NN; Chen HH; Rong Y; Lu BJ; Yang M; Jiang F; Dong SS; Guo Y; Yang TL
J Invest Dermatol; 2020 Feb; 140(2):348-360.e11. PubMed ID: 31421124
[TBL] [Abstract][Full Text] [Related]
23. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
24. The osteoporosis risk variant rs9820407 at 3p22.1 acts as an allele-specific enhancer to regulate CTNNB1 expression by long-range chromatin loop formation.
Wang Y; Lu L; Niu Y; Zhang Q; Cheng C; Huang H; Huang X; Huang Q
Bone; 2021 Dec; 153():116165. PubMed ID: 34461284
[TBL] [Abstract][Full Text] [Related]
25. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
Ward SB; Hernandez-Hoyos G; Chen F; Waterman M; Reeves R; Rothenberg EV
Nucleic Acids Res; 1998 Jun; 26(12):2923-34. PubMed ID: 9611237
[TBL] [Abstract][Full Text] [Related]
26. B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.
Zaknoen SL; Christian SL; Suen R; Van Ness B; Kay NE
Leukemia; 1992 Jul; 6(7):675-9. PubMed ID: 1625486
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Long-Range Chromatin Interaction Controls Expression of IL-21 in CD4+ T Cells.
Park JH; Choi Y; Song MJ; Park K; Lee JJ; Kim HP
J Immunol; 2016 May; 196(10):4378-89. PubMed ID: 27067007
[TBL] [Abstract][Full Text] [Related]
28. Gene regulation: from genetic variation to phenotype via chromatin.
Stower H
Nat Rev Genet; 2013 Dec; 14(12):824. PubMed ID: 24166029
[No Abstract] [Full Text] [Related]
29. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions.
Gothard LQ; Hibbard JC; Seyfred MA
Mol Endocrinol; 1996 Feb; 10(2):185-95. PubMed ID: 8825558
[TBL] [Abstract][Full Text] [Related]
30. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
31. The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)
Lu M; McComish BJ; Burdon KP; Taylor BV; Körner H
Front Immunol; 2019; 10():488. PubMed ID: 30941131
[TBL] [Abstract][Full Text] [Related]
32. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract][Full Text] [Related]
33. Developmental Transcriptional Enhancers: A Subtle Interplay between Accessibility and Activity: Considering Quantitative Accessibility Changes between Different Regulatory States of an Enhancer Deconvolutes the Complex Relationship between Accessibility and Activity.
Bozek M; Gompel N
Bioessays; 2020 Apr; 42(4):e1900188. PubMed ID: 32142172
[TBL] [Abstract][Full Text] [Related]
34. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
36. Quantification of Differential Transcription Factor Activity and Multiomics-Based Classification into Activators and Repressors: diffTF.
Berest I; Arnold C; Reyes-Palomares A; Palla G; Rasmussen KD; Giles H; Bruch PM; Huber W; Dietrich S; Helin K; Zaugg JB
Cell Rep; 2019 Dec; 29(10):3147-3159.e12. PubMed ID: 31801079
[TBL] [Abstract][Full Text] [Related]
37. Modeling gene regulation from paired expression and chromatin accessibility data.
Duren Z; Chen X; Jiang R; Wang Y; Wong WH
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4914-E4923. PubMed ID: 28576882
[TBL] [Abstract][Full Text] [Related]
38. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
Liu Z; Garrard WT
Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
[TBL] [Abstract][Full Text] [Related]
39. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes.
Thai MV; Guruswamy S; Cao KT; Pessin JE; Olson AL
J Biol Chem; 1998 Jun; 273(23):14285-92. PubMed ID: 9603935
[TBL] [Abstract][Full Text] [Related]
40. Takayasu arteritis risk locus in
Kong X; Sawalha AH
Ann Rheum Dis; 2019 Oct; 78(10):1388-1397. PubMed ID: 31315839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
